# Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:

> **NCT06281379** · NA · COMPLETED · sponsor: **Başakşehir Çam & Sakura City Hospital** · enrollment: 37 (actual)

## Conditions studied

- Gastric Cancer
- Gastric Neoplasm
- Gastric Cancer Stage

## Interventions

- **PROCEDURE:** Total mesogastrectomy

## Key facts

- **NCT ID:** NCT06281379
- **Lead sponsor:** Başakşehir Çam & Sakura City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281379, "Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06281379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*